Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1381

1.

Pseudoprogression in previously treated patients with non-small cell lung cancer who received nivolumab monotherapy: A multicenter retrospective cohort study.

Fujimoto D, Yoshioka H, Kataoka Y, Morimoto T, Hata T, Kim YH, Tomii K, Ishida T, Hirabayashi M, Hara S, Ishitoko M, Fukuda Y, Hwang MH, Sakai N, Fukui M, Nakaji H, Morita M, Mio T, Yasuda T, Sugita T, Hirai T.

J Thorac Oncol. 2018 Nov 20. pii: S1556-0864(18)33418-X. doi: 10.1016/j.jtho.2018.10.167. [Epub ahead of print]

PMID:
30468872
2.

Phase II Study of Weekly Amrubicin for Refractory or Relapsed Small Cell Lung Cancer.

Yoshioka H, Kogure Y, Ando M, Kitagawa C, Iwasaku M, Niwa T, Saka H.

In Vivo. 2018 Nov-Dec;32(6):1581-1586. doi: 10.21873/invivo.11417.

PMID:
30348719
3.

Neuroprotective effects of microglial P2Y1 receptors against ischemic neuronal injury.

Fukumoto Y, Tanaka KF, Parajuli B, Shibata K, Yoshioka H, Kanemaru K, Gachet C, Ikenaka K, Koizumi S, Kinouchi H.

J Cereb Blood Flow Metab. 2018 Oct 18:271678X18805317. doi: 10.1177/0271678X18805317. [Epub ahead of print]

PMID:
30334687
4.

1O, 20O-diacetyl kamebakaurin protects against acetaminophen-induced hepatotoxicity in mice.

Yoshioka H, Nonogaki T, Ohnishi H, Fukuishi N, Yoshikawa M, Gui MY, Jin YR, Li XW, Adachi Y, Ohno N, Takeya K, Hitotsuyanagi Y, Miura N, Aoyagi Y.

Biomed Res. 2018;39(5):251-260. doi: 10.2220/biomedres.39.251.

5.

Excessive hair growth in a patient with psoriatic erythroderma following secukinumab administration.

Mashima E, Sawada Y, Yamaguchi T, Yoshioka H, Ohmori S, Haruyama S, Okada E, Nakamura M.

Eur J Dermatol. 2018 Aug 1;28(4):539-540. doi: 10.1684/ejd.2018.3327. No abstract available.

PMID:
30325327
6.

Stochastic differential game for management of non-renewable fishery resource under model ambiguity.

Yoshioka H, Yaegashi Y.

J Biol Dyn. 2018 Dec;12(1):817-845. doi: 10.1080/17513758.2018.1528394.

PMID:
30325271
7.

Sasa veitchii extract protects against carbon tetrachloride-induced hepatic fibrosis in mice.

Yoshioka H, Nonogaki T, Fukaya S, Ichimaru Y, Nagatsu A, Yoshikawa M, Fujii H, Nakao M.

Environ Health Prev Med. 2018 Oct 15;23(1):49. doi: 10.1186/s12199-018-0739-7.

8.

Embolization of a peripheral cerebral aneurysm associated with intracranial major artery occlusion through a transdural anastomotic artery: Case report.

Fukuda N, Kanemaru K, Hashimoto K, Yoshioka H, Senbokuya N, Yagi T, Kinouchi H.

Interv Neuroradiol. 2018 Sep 19:1591019918801539. doi: 10.1177/1591019918801539. [Epub ahead of print]

PMID:
30231796
9.

Profile fluctuation of peripheral blood in advanced melanoma patients treated with nivolumab.

Saito R, Sawada Y, Saito-Sasaki N, Yamamoto K, Yoshioka H, Ohmori S, Yoshioka M, Okada E, Nakamura M.

J Dermatol. 2018 Dec;45(12):1452-1455. doi: 10.1111/1346-8138.14643. Epub 2018 Sep 11.

PMID:
30204257
10.

Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer.

Niki M, Nakaya A, Kurata T, Yoshioka H, Kaneda T, Kibata K, Ogata M, Nomura S.

Oncotarget. 2018 Aug 17;9(64):32298-32304. doi: 10.18632/oncotarget.25949. eCollection 2018 Aug 17.

11.

DNA-loaded nano-adjuvant formed with a vitamin E-scaffold intracellular environmentally-responsive lipid-like material for cancer immunotherapy.

Kawai M, Nakamura T, Miura N, Maeta M, Tanaka H, Ueda K, Higashi K, Moribe K, Tange K, Nakai Y, Yoshioka H, Harashima H, Akita H.

Nanomedicine. 2018 Nov;14(8):2587-2597. doi: 10.1016/j.nano.2018.08.006. Epub 2018 Aug 29.

PMID:
30170077
12.

Surgical outcomes and complications of pneumonectomy after induction therapy for non-small cell lung cancer.

Kayawake H, Okumura N, Yamanashi K, Otsuki Y, Takahashi A, Itasaka S, Yoshioka H, Nakashima T, Matsuoka T.

Gen Thorac Cardiovasc Surg. 2018 Nov;66(11):658-663. doi: 10.1007/s11748-018-0980-4. Epub 2018 Aug 6.

PMID:
30083866
13.

Microbial community structure in deep natural gas-bearing aquifers subjected to sulfate-containing fluid injection.

Katayama T, Yoshioka H, Yamanaka T, Takeuchi M, Muramoto Y, Usami J, Ikeda H, Sakata S.

J Biosci Bioeng. 2018 Aug 3. pii: S1389-1723(17)31269-0. doi: 10.1016/j.jbiosc.2018.06.013. [Epub ahead of print]

PMID:
30082219
14.

Development of an Alcohol Dilution-Lyophilization Method for Preparing Lipid Nanoparticles Containing Encapsulated siRNA.

Shirane D, Tanaka H, Nakai Y, Yoshioka H, Akita H.

Biol Pharm Bull. 2018;41(8):1291-1294. doi: 10.1248/bpb.b18-00208.

15.

Expression levels of brown/beige adipocyte-related genes in fat depots of vitamin A-restricted fattening cattle.

Chen HJ, Ihara T, Yoshioka H, Itoyama E, Kitamura S, Nagase H, Murakami H, Hoshino Y, Murakami M, Tomonaga S, Matsui T, Funaba M.

J Anim Sci. 2018 Jun 15. doi: 10.1093/jas/sky240. [Epub ahead of print]

PMID:
29912360
16.

Potentiating effect of acetaminophen and carbon tetrachloride-induced hepatotoxicity is mediated by activation of receptor interaction protein in mice.

Yoshioka H, Ichimaru Y, Fukaya S, Nagatsu A, Nonogaki T.

Toxicol Mech Methods. 2018 Oct;28(8):615-621. doi: 10.1080/15376516.2018.1485804. Epub 2018 Aug 2.

PMID:
29873576
17.

Intragenic copy number variation within human epiplakin 1 (EPPK1) generates variation of molecular size of epiplakin.

Ishikawa K, Furuhashi M, Sasaki T, Kudoh J, Tsuchisaka A, Hashimoto T, Sasaki T, Yoshioka H, Eshima N, Matsuda-Hirose H, Sakai T, Hatano Y, Fujiwara S.

J Dermatol Sci. 2018 May 24. pii: S0923-1811(18)30234-2. doi: 10.1016/j.jdermsci.2018.05.008. [Epub ahead of print] No abstract available.

PMID:
29866520
18.

Alopecia Areata-like Hair Loss Accompanying Toxic Epidermal Necrolysis.

Mashima E, Sawada Y, Inoue A, Saito-Sasaki N, Yamaguchi T, Yoshioka H, Ohmori S, Haruyama S, Yoshioka M, Okada E, Nakamura M.

Acta Derm Venereol. 2018 Oct 10;98(9):906-907. doi: 10.2340/00015555-2982. No abstract available.

19.

Model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients.

Yoshioka H, Sato H, Hatakeyama H, Hisaka A.

Blood Adv. 2018 May 22;2(10):1066-1075. doi: 10.1182/bloodadvances.2017013805.

20.

Novel valosin-containing protein mutations associated with multisystem proteinopathy.

Al-Tahan S, Al-Obeidi E, Yoshioka H, Lakatos A, Weiss L, Grafe M, Palmio J, Wicklund M, Harati Y, Omizo M, Udd B, Kimonis V.

Neuromuscul Disord. 2018 Jun;28(6):491-501. doi: 10.1016/j.nmd.2018.04.007. Epub 2018 Apr 17.

PMID:
29754758
21.

A singular stochastic control model for sustainable population management of the fish-eating waterfowl Phalacrocorax carbo.

Yaegashi Y, Yoshioka H, Unami K, Fujihara M.

J Environ Manage. 2018 Aug 1;219:18-27. doi: 10.1016/j.jenvman.2018.04.099. Epub 2018 Apr 30.

PMID:
29723745
22.

An optimal stopping approach for onset of fish migration.

Yoshioka H, Yaegashi Y.

Theory Biosci. 2018 Nov;137(2):99-116. doi: 10.1007/s12064-018-0263-8. Epub 2018 May 2.

PMID:
29721787
23.

A hepatic pDNA delivery system based on an intracellular environment sensitive vitamin E-scaffold lipid-like material with the aid of an anti-inflammatory drug.

Togashi R, Tanaka H, Nakamura S, Yokota H, Tange K, Nakai Y, Yoshioka H, Harashima H, Akita H.

J Control Release. 2018 Jun 10;279:262-270. doi: 10.1016/j.jconrel.2018.04.022. Epub 2018 Apr 17.

PMID:
29673647
24.

Assessing patterns of T2/T1rho change in grade 1 cartilage lesions of the distal femur using an angle/layer dependent approach.

Kaneko Y, Nozaki T, Yu H, Schwarzkopf R, Hara T, Yoshioka H.

Clin Imaging. 2018 Jul - Aug;50:201-207. doi: 10.1016/j.clinimag.2018.03.017. Epub 2018 Apr 7.

PMID:
29660530
25.

Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study.

Fujimoto D, Yoshioka H, Kataoka Y, Morimoto T, Kim YH, Tomii K, Ishida T, Hirabayashi M, Hara S, Ishitoko M, Fukuda Y, Hwang MH, Sakai N, Fukui M, Nakaji H, Morita M, Mio T, Yasuda T, Sugita T, Hirai T.

Lung Cancer. 2018 May;119:14-20. doi: 10.1016/j.lungcan.2018.02.017. Epub 2018 Mar 2.

PMID:
29656747
26.

In Vivo Introduction of mRNA Encapsulated in Lipid Nanoparticles to Brain Neuronal Cells and Astrocytes via Intracerebroventricular Administration.

Tanaka H, Nakatani T, Furihata T, Tange K, Nakai Y, Yoshioka H, Harashima H, Akita H.

Mol Pharm. 2018 May 7;15(5):2060-2067. doi: 10.1021/acs.molpharmaceut.7b01084. Epub 2018 Apr 11.

PMID:
29638135
27.

Soluble Klotho causes hypomineralization in Klotho-deficient mice.

Minamizaki T, Konishi Y, Sakurai K, Yoshioka H, Aubin JE, Kozai K, Yoshiko Y.

J Endocrinol. 2018 Jun;237(3):285-300. doi: 10.1530/JOE-17-0683. Epub 2018 Apr 9.

PMID:
29632215
28.

Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression.

Saito-Sasaki N, Sawada Y, Mashima E, Yamaguchi T, Ohmori S, Yoshioka H, Haruyama S, Okada E, Nakamura M.

Sci Rep. 2018 Apr 3;8(1):5522. doi: 10.1038/s41598-018-23623-9.

29.

Organic-inorganic hybrid microdisk laser with dye and silica mixed doping prepared by ink-jet printing method.

Mikami Y, Yoshioka H, Ryu S, Nishimura N, Oki Y.

Opt Express. 2018 Mar 19;26(6):7140-7147. doi: 10.1364/OE.26.007140.

PMID:
29609400
30.

Comparison Between Isotropic 3-Dimensional Fat-Suppressed T2-Weighted Fast Spin Echo (FSE) and Conventional 2-Dimensional Fat-Suppressed Proton-Weighted FSE Shoulder Magnetic Resonance Imaging at 3-T in Patients With Shoulder Pain.

Horiuchi S, Nozaki T, Tasaki A, Ohde S, Deshpande GA, Starkey J, Hara T, Kitamura N, Yoshioka H.

J Comput Assist Tomogr. 2018 Jul/Aug;42(4):559-565. doi: 10.1097/RCT.0000000000000721.

PMID:
29489594
31.

Lethal chronotoxicity induced by seven metal compounds in mice.

Yoshioka H, Nonogaki T, Shinohara Y, Suzui M, Mori Y, Hwang GW, Ohtani K, Miura N.

J Toxicol Sci. 2018;43(2):129-134. doi: 10.2131/jts.43.129.

32.

Singular stochastic control model for algae growth management in dam downstream.

Yoshioka H, Yaegashi Y.

J Biol Dyn. 2018 Dec;12(1):242-270. doi: 10.1080/17513758.2018.1436197.

PMID:
29461937
33.

Identification of G-quadruplex clusters by high-throughput sequencing of whole-genome amplified products with a G-quadruplex ligand.

Yoshida W, Saikyo H, Nakabayashi K, Yoshioka H, Bay DH, Iida K, Kawai T, Hata K, Ikebukuro K, Nagasawa K, Karube I.

Sci Rep. 2018 Feb 15;8(1):3116. doi: 10.1038/s41598-018-21514-7.

34.

Preparation of molecularly imprinted polymer nanobeads for selective sensing of carboxylic acid vapors.

Liu C, Shang L, Yoshioka HT, Chen B, Hayashi K.

Anal Chim Acta. 2018 Jun 20;1010:1-10. doi: 10.1016/j.aca.2018.01.004. Epub 2018 Jan 30.

PMID:
29447665
35.

Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab.

Nakaya A, Kurata T, Yoshioka H, Takeyasu Y, Niki M, Kibata K, Satsutani N, Ogata M, Miyara T, Nomura S.

Int J Clin Oncol. 2018 Aug;23(4):634-640. doi: 10.1007/s10147-018-1250-2. Epub 2018 Feb 13.

36.

A high expression of cell adhesion molecule 1 (CADM1) is an unfavorable prognostic factor in mycosis fungoides.

Mashima E, Sawada Y, Yamaguchi T, Yoshioka H, Ohmori S, Haruyama S, Yoshioka M, Okada E, Nakamura M.

Clin Immunol. 2018 Aug;193:121-122. doi: 10.1016/j.clim.2018.01.005. Epub 2018 Jan 31. No abstract available.

PMID:
29391198
37.

Methyl dehydroabietate counters high fat diet-induced insulin resistance and hepatic steatosis by modulating peroxisome proliferator-activated receptor signaling in mice.

Yoshioka H, Mizuno Y, Yamaguchi T, Ichimaru Y, Takeya K, Hitotsuyanagi Y, Nonogaki T, Aoyagi Y.

Biomed Pharmacother. 2018 Mar;99:214-219. doi: 10.1016/j.biopha.2018.01.064.

PMID:
29334664
38.

Effects of edge inclination angles on whispering-gallery modes in printable wedge microdisk lasers.

Chen C, Wan L, Chandrahalim H, Zhou J, Zhang H, Cho S, Mei T, Yoshioka H, Tian H, Nishimura N, Fan X, Guo LJ, Oki Y.

Opt Express. 2018 Jan 8;26(1):233-241. doi: 10.1364/OE.26.000233.

PMID:
29328300
39.

Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer.

Kaneda T, Yoshioka H, Tamiya M, Tamiya A, Hata A, Okada A, Niwa T, Shiroyama T, Kanazu M, Ishida T, Katakami N.

BMC Cancer. 2018 Jan 2;18(1):6. doi: 10.1186/s12885-017-3952-7.

40.

Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non-small Cell Lung Cancer.

Kataoka Y, Hirano K, Narabayashi T, Hara S, Fujimoto D, Tanaka T, Ebi N, Tomii K, Yoshioka H.

Anticancer Res. 2018 Jan;38(1):559-563.

PMID:
29277824
41.

Regulation of type I collagen expression by microRNA-29 following ionizing radiation.

Yano H, Hamanaka R, Nakamura-Ota M, Zhang JJ, Matsuo N, Yoshioka H.

Radiat Environ Biophys. 2018 Mar;57(1):41-54. doi: 10.1007/s00411-017-0723-4. Epub 2017 Dec 11.

PMID:
29230533
42.

Concordance between the response evaluation criteria in solid tumors version 1.1 and the immune-related response criteria in patients with non-small cell lung cancer treated with nivolumab: a multicenter retrospective cohort study.

Kataoka Y, Hirano K, Narabayashi T, Hara S, Fujimoto D, Tanaka T, Ebi N, Tomii K, Yoshioka H.

Cancer Chemother Pharmacol. 2018 Feb;81(2):333-337. doi: 10.1007/s00280-017-3498-z. Epub 2017 Dec 11.

PMID:
29230503
43.

A case of empyema and septic arthritis due to Nocardia farcinica.

Ishiguro T, Yoshioka H, Kawai S, Katsumata SI, Gonoi T, Takayanagi N.

Clin Case Rep. 2017 Oct 24;5(12):1976-1979. doi: 10.1002/ccr3.1228. eCollection 2017 Dec.

44.

Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status.

Ikeda S, Yoshioka H, Ikeo S, Morita M, Sone N, Niwa T, Nishiyama A, Yokoyama T, Sekine A, Ogura T, Ishida T.

BMC Cancer. 2017 Nov 28;17(1):797. doi: 10.1186/s12885-017-3814-3.

45.

Initial inferior vena cava diameter predicts massive transfusion requirements in blunt trauma patients: A retrospective cohort study.

Takada H, Hifumi T, Yoshioka H, Okada I, Kiriu N, Inoue J, Morimoto K, Matsumoto J, Koido Y, Kato H.

Am J Emerg Med. 2018 Jul;36(7):1155-1159. doi: 10.1016/j.ajem.2017.11.049. Epub 2017 Nov 21.

PMID:
29174329
46.

Sasa veitchii extracts suppress acetaminophen-induced hepatotoxicity in mice.

Yoshioka H, Usuda H, Fujii H, Nonogaki T.

Environ Health Prev Med. 2017 Jun 12;22(1):54. doi: 10.1186/s12199-017-0662-3.

47.

Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer.

Watanabe SI, Nakagawa K, Suzuki K, Takamochi K, Ito H, Okami J, Aokage K, Saji H, Yoshioka H, Zenke Y, Aoki T, Tsutani Y, Okada M; Lung Cancer Surgical Study Group (LCSSG) of the Japan Clinical Oncology Group (JCOG).

Jpn J Clin Oncol. 2017 Dec 1;47(12):1112-1118. doi: 10.1093/jjco/hyx147. Review.

PMID:
29136212
48.

[Delayed Tracheal Perforation after Pulmonary Resection for Lung Cancer].

Hashimoto K, Takada M, Sato K, Yoshioka H.

Kyobu Geka. 2017 Nov;70(12):991-993. Japanese.

PMID:
29104197
49.

Preparation of envelope-type lipid nanoparticles containing gold nanorods for photothermal cancer therapy.

Paraiso WKD, Tanaka H, Sato Y, Shirane D, Suzuki N, Ogra Y, Tange K, Nakai Y, Yoshioka H, Harashima H, Akita H.

Colloids Surf B Biointerfaces. 2017 Dec 1;160:715-723. doi: 10.1016/j.colsurfb.2017.10.027. Epub 2017 Oct 9.

PMID:
29035819
50.

Nonconcordant regulation of mitochondrial respiratory complexes in the kidneys of 5/6 nephrectomized mice.

Nakashita Y, Sano T, Yoshioka H, Shimada T, Hori R, Usami M, Hamada Y.

J Med Invest. 2017;64(3.4):255-261. doi: 10.2152/jmi.64.255.

Supplemental Content

Loading ...
Support Center